Epilepsy Therapeutics Market in APAC Region 2019: Drivers, Trends & Growth Analysis

1
Epilepsy Therapeutics Market in the APAC Region
2015-2019
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published December 2014
• Single User PDF US 2500
• Corporate User PDF US 3500

2
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• Epilepsy is a spectrum of brain disorders varying
  from benign to severe, disabling, and
  life-threatening symptoms. It is caused by
  various factors ranging from brain malformations
  and tumors to meningitis, high-risk pregnancies,
  and birth trauma. However, when the underlying
  cause of the disease is unidentified, as in the
  majority of the cases, it is known as idiopathic
  epilepsy. Epilepsy is characterized by repeated
  occurrence of generalized or focal seizures. An
  imbalance between the inhibitory and excitatory
  signals of the brain, leading to a sudden onset
  of excitation, results in seizures. Occurrence of
  two or more unprovoked seizures is an important
  criterion to diagnose a person as being
  epileptic.
• Analysts forecast the Epilepsy Therapeutics
  market in the APAC to grow at a CAGR of 5.78
  percent over the period 2014-2019.
• Covered in this Report
• This report covers the present scenario and the
  growth prospects of the Epilepsy Therapeutics
  market in the APAC for the period 2015-2019. To
  calculate the market size, the report considers
  the revenue generated through the sales of
  anti-epileptic drugs used for the treatment of
  the symptoms of epilepsy in APAC.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• The report also presents the vendor landscape and
  a corresponding detailed analysis of the top
  vendors in the market in the region. In addition,
  it discusses the major drivers that influence the
  growth of the market. It also outlines the
  challenges faced by the vendors and the market at
  large, as well as the key trends that are
  emerging in the market.
• Single User License US 2500 Inquire for
  Discount _at_ http//www.reportsnreports.com/contacts
  /Discount.aspx?name322414.
• Epilepsy Therapeutics Market in the APAC
  2015-2019, has been prepared based on an in-depth
  market analysis with inputs from industry
  experts. The report covers the APAC regions it
  also covers the market landscape and its growth
  prospects in the coming years. The report also
  includes a discussion of the key vendors
  operating in this market.
• Key Countries
• Australia
• China
• India
• Japan

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• Key Vendors
• Eisai, GlaxoSmithKline, Pfizer, UCB
• Other Prominent Vendors
• Abbvie, Acorda Therapeutics, Dainippon Sumitomo
  Pharma, F. Hoffmann-La Roche, H. Lundbeck,
  Janssen Pharmaceuticals, Marinus Pharmaceuticals,
  Meda AB, Novartis, Sage Therapeutics, Shire,
  Sunovion Pharmaceuticals, Supernus
  Pharmaceuticals, Upsher-Smith Laboratories,
  Valeant Pharmaceuticals
• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name322414.
• Market Driver
• Unmet Medical Need

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• Market Challenge
• Generic Erosion
• Market Trend
• Reformulation of Marketed Drugs
• Key Questions Answered in this Report
• What will the market size be in 2019 and what
  will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats
  faced by the key vendors?
• What are the strengths and weaknesses of the key
  vendors?

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• List of Exhibits
• Exhibit 1 Market Research MethodologyExhibit 2
  Incidence and Prevalence of Epilepsy by
  WHOExhibit 3 Treatment Statistics for
  EpilepsyExhibit 4 Prevalence of Epilepsy in
  ChinaExhibit 5 NIH Funding for Epilepsy (US
  million) FY2011-FY2015Exhibit 6 Epilepsy
  Therapeutics market in APAC 2014-2019 (US
  million)Exhibit 7 Epilepsy Therapeutics Market
  in APAC Segmentation by Generation of
  DrugsExhibit 8 Market Share of APAC in Global
  Epilepsy MarketExhibit 9 Epilepsy Therapeutics
  Market in APAC by Country 2014Exhibit 10
  Epilepsy Therapeutics market in APAC by Country
  2019Exhibit 11 Epilepsy Therapeutics Market in
  APAC 2014-2019 (US million)Exhibit 12 Epilepsy
  Therapeutics Market in APAC 2014-2019Exhibit 13
  Epilepsy Market in Japan 2014-2019 (US
  million)Exhibit 14 Epilepsy Market in Australia
  2014-2019 (US million)Exhibit 15 Epilepsy
  Market in China 2014-2019 (US million)Exhibit
  16 Epilepsy Market in India 2014-2019 (US
  million)Exhibit 17 Key Leading Countries in the
  Epilepsy Therapeutics market in APAC 2014Exhibit
  18 Impact of Loss of Exclusivity for Lyrica in
  Canadian market (US million)

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
7
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• Exhibit 19 GlaxoSmithKline Anti-epileptic Drug
  Portfolio in APACExhibit 20 Lamictal Revenue
  2011-2014 (US million)
• Inquiry Before Buying _at_ http//www.reportsnreports
  .com/contacts/InquiryBeforeBuy.aspx?name322414.
•  
• Exhibit 21 Lamictal Sales Segmentation by
  Geography 2014Exhibit 22 Eisai Anti-epileptic
  Drug Portfolio in APACExhibit 23 Fycompa
  Pipeline StatusExhibit 24 Inovelon Pipeline
  StatusExhibit 25 UCB Anti-epileptic Drug
  Portfolio in APACExhibit 26 Keppra Sales
  2010-2014 (US million)Exhibit 27 Keppra Sales
  by Geography 2014Exhibit 28 Vimpat Sales by
  2009-2014 (US million)Exhibit 29 Vimpat Sales
  by Geography 2014Exhibit 30 Vimpat Pipeline
  StatusExhibit 31 Lyrica Revenue 2011-2014 (US
  million)Exhibit 32 Lyrica Revenue by Geography
  2014Exhibit 33 Eisai Product Segmentation by
  Revenue 2014

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
8
Epilepsy Therapeutics Market in the APAC Region
2015-2019

• Exhibit 34 Eisai Product Segmentation by
  Revenue 2013 and 2014 (US million)Exhibit 35
  Eisai Geographical Segmentation by Revenue
  2014Exhibit 36 GlaxoSmithKline Business
  Segmentation 2014Exhibit 37 GlaxoSmithKline
  Business Segmentation by Revenue 2013 and 2014
  (US billion)Exhibit 38 GlaxoSmithKline Sales
  by Geography 2014Exhibit 39 GlaxoSmithKline
  Pipeline Products 2014Exhibit 40 Pfizer
  Business Segmentation by Revenue 2014Exhibit 41
  Pfizer Business Segmentation by Revenue 2013 and
  2014Exhibit 42 Pfizer Geographical
  Segmentation by Revenue 2014Exhibit 43 UCB
  Product Segmentation by Revenue 2014Exhibit 44
  UCB Product Segmentation by Revenue 2013 and
  2014 (US million)Exhibit 45 UCB Geographical
  Segmentation by Revenue 2014
• Explore Report on Pharmaceuticals Market.
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Epilepsy
  Therapeutics Market in the APAC Region 2015-2019
  report OR for any other market research and
  intelligence needs you may have for your
  business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.